Cargando…
T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288372/ http://dx.doi.org/10.1186/2051-1426-2-S3-O8 |
_version_ | 1782351957788196864 |
---|---|
author | Postow, Michael Manuel, Manuarii Wong, Phillip Yuan, Jianda Noel, Marlene Courtier, Anais Pasqual, Nicolas Wolchok, Jedd D |
author_facet | Postow, Michael Manuel, Manuarii Wong, Phillip Yuan, Jianda Noel, Marlene Courtier, Anais Pasqual, Nicolas Wolchok, Jedd D |
author_sort | Postow, Michael |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4288372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42883722015-01-15 T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma Postow, Michael Manuel, Manuarii Wong, Phillip Yuan, Jianda Noel, Marlene Courtier, Anais Pasqual, Nicolas Wolchok, Jedd D J Immunother Cancer Oral Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288372/ http://dx.doi.org/10.1186/2051-1426-2-S3-O8 Text en Copyright © 2014 Postow et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Oral Presentation Postow, Michael Manuel, Manuarii Wong, Phillip Yuan, Jianda Noel, Marlene Courtier, Anais Pasqual, Nicolas Wolchok, Jedd D T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma |
title | T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma |
title_full | T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma |
title_fullStr | T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma |
title_full_unstemmed | T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma |
title_short | T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma |
title_sort | t cell receptor diversity evaluation to predict patient response to ipilimumab in metastatic melanoma |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288372/ http://dx.doi.org/10.1186/2051-1426-2-S3-O8 |
work_keys_str_mv | AT postowmichael tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma AT manuelmanuarii tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma AT wongphillip tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma AT yuanjianda tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma AT noelmarlene tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma AT courtieranais tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma AT pasqualnicolas tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma AT wolchokjeddd tcellreceptordiversityevaluationtopredictpatientresponsetoipilimumabinmetastaticmelanoma |